跳至主要内容
临床试验/NCT02969096
NCT02969096Unknown2 期

Evaluating the Safety and Efficacy of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma

Shanghai University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
30
试验地点
1
主要终点
Rate of complete tumor ablation

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of targeted cryoablation therapy for hepatic carcinoma.

详细描述

A cryoprobe is inserted percutaneously under CT guidance into the targeted lesion. Patients undergo ablation using a freeze-thaw-freeze cycle lasting approximately 10-6-10minutes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of liver cancer based on histology or the current accepted radiological measures.
  • Single Tumor size ≤5.0 cm in greatest diameter, or multiple tumor number≤3 and each tumor size≤ 3cm.
  • Life expectancy: Greater than 3 months.
  • Patients' liver function is Child-pugh A or B.
  • Ability to understand the study protocol and a willingness to sign a written informed consent document.
  • Unable to receive operative surgery.

排除标准

  • Patients with other primary tumor except liver cancer.
  • History of coagulation disorders or anemia.

结局指标

主要结局

Rate of complete tumor ablation

时间窗: Up to 4 weeks post surgery

次要结局

  • Adverse Events(Up to 4 weeks post surgery)

研究者

发起方
Shanghai University of Traditional Chinese Medicine
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验